- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 6.93M sh |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.05B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.08B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.32B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.34B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 6.42K sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $579K |
| Dividends Paid restated | Q1 2025 · Mar 31, 2024 | $1.87M |
| Capex | Q1 2025 · Mar 31, 2024 | $71K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $4.83M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $172.07M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $150.56M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $241.81M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $240.21M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.68 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.69 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $119K |
| Net Income | Q1 2025 · Mar 31, 2024 | $4.35M |